HHLR ADVISORS, LTD.HHLR ADVISORS, LTD.

Institutional investor · Portfolio as of Q4 2025

Top Holdings33 positions

Checking export access…
Activity:
PDDPDD
ADR

Pinduoduo Inc

10.7M$1.2B39.2%$113.43-0.03%
15 qtrssince 2022-Q2
Increased
77
BABABABA
ADR

Alibaba Group Holding Ltd

5.4M$796M25.6%$144.74+0.35%
15 qtrssince 2022-Q2
Increased
91
ONCONC
ADR

BEIGENE LTD

1M$314.2M10.1%$136.90+121.93%
29 qtrssince 2018-Q4
Unchanged
0
FUTUFUTU
ADR

Futu Holdings Ltd

1.6M$267.7M8.6%$93.48+72.89%
7 qtrssince 2024-Q2
Decreased
0
LEGNLEGN
ADR

LEGEND BIOTECH CORP

6M$130.1M4.2%$50.33-57.22%
23 qtrssince 2020-Q2
Unchanged
0

ARRIVENT BIOPHARMA INC

3.9M$79.1M2.5%$17.95+15.46%
8 qtrssince 2024-Q1
Decreased
0
BEKEBEKE
ADR

KE HLDGS INC

4.2M$66.8M2.2%$20.87-25.84%
22 qtrssince 2020-Q3
Unchanged
0

WEBULL CORP ORD SHS

6M$46.4M1.5%$10.83-26.78%
3 qtrssince 2025-Q2
Decreased
0

CYTEK BIOSCIENCES INC

6.7M$33.6M1.1%$21.41-76.41%
18 qtrssince 2021-Q3
Unchanged
0
CWANCWANDelisted

CLEARWATER ANALYTICS HLDGS I

1.4M$32.9M1.1%$22.00+9.55%
3 qtrssince 2025-Q2
Unchanged
0
NBPNBP
ADR

I MAB

6M$23.8M0.8%$47.24-91.62%
22 qtrssince 2020-Q3
Unchanged
0
YSYSG
ADR

YATSEN HLDG LTD

4.9M$19M0.6%$10.59-62.61%
21 qtrssince 2020-Q4
Unchanged
0

MAZE THERAPEUTICS INC

457,535$19M0.6%$11.42+250.70%
4 qtrssince 2025-Q1
Unchanged
0

Gossamer Bio Inc

5M$15.4M0.5%$1,330.85-81.37%
28 qtrssince 2019-Q1
Unchanged
0
APIAPI
ADR

Agora Inc

2.1M$8.5M0.3%$4.20-4.76%
5 qtrssince 2024-Q4
Unchanged
0

CONTINEUM THERAPEUTICS INC

669,337$7.7M0.2%$17.61-35.26%
7 qtrssince 2024-Q2
Unchanged
0

SAGIMET BIOSCIENCES INC

724,800$4.3M0.1%$8.80-33.52%
10 qtrssince 2023-Q3
Unchanged
0
TSMTSM
ADR

Taiwan Semiconductor Manufactu

11,300$3.4M0.1%$301.520.00%
1 qtr
New
45
TUYATUYA
ADR

TUYA INC

1.6M$3.3M0.1%$19.21-88.86%
20 qtrssince 2021-Q1
Unchanged
0

General Electric Co

10,043$3.1M0.1%$205.55+49.23%
8 qtrssince 2024-Q1
Unchanged
0
$3.1B
AUM
33
Positions
Q4 2025
Filing
HI score · 2.5/5
Quarterly 13F Value Change
+12%Q3'24$4.6B-37%Q4'24$2.9B+23%Q1'25$3.5B-12%Q2'25$3.1B+32%Q3'25$4.1B-24%Q4'25$3.1B
Activity profile
$ moved · Q4'25
New1%Increased20%Decreased51%Exited29%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.9 years
<1Q12%1-4Q15%1-2Y24%2Y+48%

HHLR ADVISORS, LTD. manages $3.1B across 33 positions as of Q4 2025. Top holdings: PDD (39.2%), BABA (25.6%), ONC (10.1%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 2.5/5.0.

Q4 2025 Summary

Active quarter - 6 new positions, 6 exits, 2 increased. Top move: BABA (INCREASED, conviction 91). Portfolio: $3.1B across 33 positions.

Top holdings by portfolio weight

Total AUM$3B
PDD39.17%
BABA25.65%
ONC10.12%
FUTU8.63%
LEGN4.19%
AVBP2.55%
BEKE2.15%
BULL1.50%
CTKB1.08%
CWAN1.06%
Other0.77%

Portfolio allocation by GICS sector

Sectors11
Consumer Cyclical64.88%
Healthcare20.29%
Financial Services8.67%
Technology3.06%
Real Estate2.15%
Consumer Defensive0.61%
Industrials0.10%
Communication Services0.07%
Basic Materials0.07%
Unknown0.06%
Other0.03%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Consumer Cyclical, Healthcare
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Solid(2.5 / 5.0)
Holdings P&L26
Conviction41
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used